The Antidepressant Web: Marketing depression and making medicines work
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
This paper was conceived as chapters two and three of the still unwritten book, and as a basis for discussion on an Internet website and elsewhere. These chapters examine hard evidence relating to a wholly rhetorical and hypothetical question, "Do antidepressants work?" The question provides the broadest possible framework for looking at the meaning and values of medicine. Implicitly, the question also asks: what is better than nothing, and how much better are antidepressant drugs than the placebos they are compared with in clinical trials? Between the lines of the paper lie basic questions about the ethics, activities, performance and impact of the three main centres of power in medicine - government, professionals and the pharmaceutical industry. The underlying issue is whether people who are miserably unfulfilled, sad, anguished or depressed are in hands as safe as they might imagine or need.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
A History of Psychiatry: From the Era of the Asylum to the Age of Prozac.
Herman, E., & Shorter, E. (1997) · The Journal of American History · doi:10.2307/2953108 · Cited by 1,056
Hirschfeld, R. M. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540280071036 · Cited by 895
Drugs and the treatment of psychiatric disorders
Baldessarini, R. J. (1996) · Medical Entomology and Zoology · Cited by 683
Recognition and management of depression in general practice: consensus statement
Paykel, E. S., & Priest, R. G. (1992) · BMJ · doi:10.1136/bmj.305.6863.1198 · Cited by 540
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399
Priest, R. G., Vize, C., Roberts, A., Roberts, M., & Tylee, A. (1996) · BMJ · doi:10.1136/bmj.313.7061.858 · Cited by 385
Withdrawal from long-term benzodiazepine treatment
Petursson, H., & Lader, M. H. (1981) · BMJ · doi:10.1136/bmj.283.6292.643 · Cited by 367
[Long-term treatment of depression].
Keller, M. B. (1994) · PubMed · Cited by 362
Jick, S. S., Dean, A. D., & Jick, H. (1995) · BMJ · doi:10.1136/bmj.310.6974.215 · Cited by 249
Cited by
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436
Antidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Martinez, C., Rietbrock, S., Wise, L., Ashby, D., Chick, J., Moseley, J., Evans, S., & Gunnell, D. (2005) · BMJ · doi:10.1136/bmj.330.7488.389 · Cited by 240
Can long-term treatment with antidepressant drugs worsen the course of depression?
Fava, G. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0204 · Cited by 223
The mechanisms of tolerance in antidepressant action
Fava, G. A., & Offidani, E. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.026 · Cited by 158
“They have been described with any type of antidepressant drugs (Dilsalver, 1990), and particularly MAO inhibitors and SSRI (Lejoyeux et al., 1996; Zajecka et al., 1997; Medawar, 1997; Oliver et al., 1999; Rosenbaum et al., 1998).”
Metadata
- Authors
- Medawar, C.
- Affiliations
- Social Audit Ltd., P.O. Box 111, London NWI 8XG, UK
- Corresponding author
- Medawar, Charles
- Venue
- International Journal of Risk and Safety in Medicine
- Publisher
- SAGE Publications
- Published
- 1997
- Volume
- 10
- Issue
- 2
- Pages
- 75-126
- ISSN
- 0924-6479 (ISSN-L)
- OpenAlex
- W2280939070
- Cited by
- 92
- References
- 65
- Citations by year
- 2024: 1 · 2022: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2016: 1 · 2015: 3 · 2013: 14
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Risk & Safety in Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- antidepressants, antidepressant efficacy, placebo comparison, clinical trials, medical ethics, pharmaceutical industry, government regulation of medicine, medical professionals, patient safety, depression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Antidepressant Web: Marketing depression and making medicines work. https://app.cochat.ai/papers/10.3233/jrs-1997-10203
- The paper
- Medawar, C. (1997). The Antidepressant Web: Marketing depression and making medicines work. International Journal of Risk and Safety in Medicine. https://doi.org/10.3233/jrs-1997-10203
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.